Delivery Order SPE2DB25D3504-SPE2DB25FVWJA
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of YONSA (abiraterone acetate) 125 mg tablets in a quantity of 120 units, valued at $2,271.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- AmerisourceBergen Drug Corp received a $2,271.36 delivery order from the Defense Logistics Agency (DLA) on May 13, 2025, for the supply of YONSA 125 mg tablets (120-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside procurement awarded through competitive means, consistent with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yonsa 125 mg tablets (120-count units) valued at $4,542.74. This firm fixed-price, competitively awarded contract has an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Yonsa 125 mg tablets (120 count) valued at $2,271.36, with completion expected by October 2, 2025. This competitive award utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,085.44 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product supporting military healthcare needs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product. The contract, awarded on August 12, 2025, carries a firm fixed-price structure with an ultimate completion date of September 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) under a firm fixed-price contract type. The award, valued at $6.8K, was made on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,814.08 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract. The award was issued on September 2, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $4,542.74 and completion date of July 11, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWJADelivery Order
The Defense Logistics Agency awarded a $2.27K delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for supply of YONSA (abiraterone acetate) 125 mg tablets in a 120-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99M and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the Defense Logistics Agency. The company's SPE2DX prime contract enables delivery of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. All of AmerisourceBergen's reviewed federal awards have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements across transaction sizes ranging from under $100 to over $45K.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/15/25 |